Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Kaufmann

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Breast (Edinburgh, Scotland)|February 19, 2008
Understanding the data, meeting patients' needsManfred Kaufmann
Deutsches Arzteblatt International|July 2, 2009
Correspondence (letter to the editor): imaging is not sufficientManfred Kaufmann
Breast Care (Basel, Switzerland)|March 5, 2011
Guidelines - Inflation or Help in Clinical Routine?Manfred Kaufmann
Cancer|April 8, 2011
Use of standard markers and incorporation of molecular markers into breast cancer therapy: Consensus recommendations from an International Expert PanelManfred Kaufmann, Lajos Pusztai,
Journal of Cancer Research and Clinical Oncology|May 26, 2005
Long-term risk of breast cancer recurrence: the need for extended adjuvant therapyManfred Kaufmann, Achim Rody
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 20, 2006
Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen: why, who and how long?Manfred Kaufmann, Achim Rody
Expert Opinion on Drug Safety|March 21, 2007
Aromatase inhibitors: a safety comparisonWalter Jonat, Felix Hilpert, Manfred Kaufmann
Breast Care (Basel, Switzerland)|March 5, 2011
Adjuvant Consensus: A Breast Cancer Patient Web ToolWalter Jonat, Christoph Mundhenke, Manfred Kaufmann
World Journal of Surgery|January 27, 2012
Controversies concerning the use of neoadjuvant systemic therapy for primary breast cancerManfred Kaufmann, Thomas Karn, Eugen Ruckhäberle
Breast (Edinburgh, Scotland)|October 4, 2005
Preoperative (neoadjuvant) systemic treatment of breast cancerManfred Kaufmann, Gunter von Minckwitz, Achim Rody
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Breast (Edinburgh, Scotland)|February 19, 2008
Understanding the data, meeting patients' needsManfred Kaufmann
Deutsches Arzteblatt International|July 2, 2009
Correspondence (letter to the editor): imaging is not sufficientManfred Kaufmann
Breast Care (Basel, Switzerland)|March 5, 2011
Guidelines - Inflation or Help in Clinical Routine?Manfred Kaufmann
Cancer|April 8, 2011
Use of standard markers and incorporation of molecular markers into breast cancer therapy: Consensus recommendations from an International Expert PanelManfred Kaufmann, Lajos Pusztai,
Journal of Cancer Research and Clinical Oncology|May 26, 2005
Long-term risk of breast cancer recurrence: the need for extended adjuvant therapyManfred Kaufmann, Achim Rody
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 20, 2006
Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen: why, who and how long?Manfred Kaufmann, Achim Rody
Expert Opinion on Drug Safety|March 21, 2007
Aromatase inhibitors: a safety comparisonWalter Jonat, Felix Hilpert, Manfred Kaufmann
Breast Care (Basel, Switzerland)|March 5, 2011
Adjuvant Consensus: A Breast Cancer Patient Web ToolWalter Jonat, Christoph Mundhenke, Manfred Kaufmann
World Journal of Surgery|January 27, 2012
Controversies concerning the use of neoadjuvant systemic therapy for primary breast cancerManfred Kaufmann, Thomas Karn, Eugen Ruckhäberle
Breast (Edinburgh, Scotland)|October 4, 2005
Preoperative (neoadjuvant) systemic treatment of breast cancerManfred Kaufmann, Gunter von Minckwitz, Achim Rody
Pageof 15